What does CUSIP 514766104 represent in this 13F holders report?

CUSIP 514766104 is the security identifier for LFCR - LIFECORE BIOMEDICAL, INC. DE - Common Stock used to aggregate holder disclosures.

How many institutions held LFCR - LIFECORE BIOMEDICAL, INC. DE - Common Stock in Q4 2022?

92 institutional investors reported LFCR - LIFECORE BIOMEDICAL, INC. DE - Common Stock for Q4 2022. Use the holders table for investor-level position and value details.

LIFECORE BIOMEDICAL, INC. DE - Common Stock (LFCR)

CUSIP: 514766104

Q4 2022 13F Holders as of 31 Dec 2022

Type / Class: Equity / Common Stock
Shares outstanding: 37,508,353
Total 13F shares: 24,699,229
Share change: -58,931
Total reported value: $160,060,929
Put/Call ratio: 1084%
Price per share: $6.48
Number of holders: 92
Value change: -$420,882
Number of buys: 41
Number of sells: 29

Quarterly Holders Quick Answers

What is CUSIP 514766104?
CUSIP 514766104 identifies LFCR - LIFECORE BIOMEDICAL, INC. DE - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2023
Previous quarter: Q3 2022

Recent filing periods for CUSIP 514766104:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of LFCR - LIFECORE BIOMEDICAL, INC. DE - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
WYNNEFIELD CAPITAL INC	13F	Company	9.4%	3,533,287	$31,411,000	—	30 Sep 2022	13F
Legion Partners Asset Management, LLC	13F	Company	7.8%	2,940,340	$26,140,000	—	30 Sep 2022	13F
Cove Street Capital, LLC	13F	Company	5%	1,888,494	$16,788,000	—	30 Sep 2022	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	4.9%	1,833,902	$16,304,000	—	30 Sep 2022	13F
BlackRock Finance, Inc.	13F	Company	4.8%	1,807,246	$16,067,000	—	30 Sep 2022	13F
22NW, LP	13F	Company	4.7%	1,755,161	$15,603,000	—	30 Sep 2022	13F
ISZO CAPITAL MANAGEMENT LP	13F	Company	4.1%	1,530,652	$13,607,000	—	30 Sep 2022	13F
VANGUARD GROUP INC	13F	Company	3.4%	1,268,099	$11,273,000	—	30 Sep 2022	13F
HEARTLAND ADVISORS INC	13F	Company	3.2%	1,208,850	$10,747,000	—	30 Sep 2022	13F
PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC.	13F	Company	1.9%	723,200	$6,429,000	—	30 Sep 2022	13F
MORGAN STANLEY	13F	Company	1.6%	614,979	$5,466,000	—	30 Sep 2022	13F
TOCQUEVILLE ASSET MANAGEMENT L.P.	13F	Company	1.6%	602,900	$5,360,000	—	30 Sep 2022	13F
Visionary Wealth Advisors	13F	Company	1.4%	524,489	$4,663,000	—	30 Sep 2022	13F
STATE STREET CORP	13F	Company	1.3%	498,057	$4,428,000	—	30 Sep 2022	13F
Pacific Ridge Capital Partners, LLC	13F	Company	1.3%	485,770	$4,318,000	—	30 Sep 2022	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	1.2%	464,646	$4,130,000	—	30 Sep 2022	13F
Russell Investments Group, Ltd.	13F	Company	0.78%	291,770	$2,593,000	—	30 Sep 2022	13F
NORTHERN TRUST CORP	13F	Company	0.61%	227,760	$2,025,000	—	30 Sep 2022	13F
Parkman Healthcare Partners LLC	13F	Company	0.54%	202,248	$1,798,000	—	30 Sep 2022	13F
Point72 Asset Management, L.P.	13F	Company	0.5%	186,204	$1,655,000	—	30 Sep 2022	13F
Assenagon Asset Management S.A.	13F	Company	0.4%	148,803	$1,323,000	—	30 Sep 2022	13F
ROYAL BANK OF CANADA	13F	Company	0.39%	147,319	$1,310,000	—	30 Sep 2022	13F
Boston Partners	13F	Company	0.33%	124,945	$1,111,000	—	30 Sep 2022	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.32%	118,900	$1,057,000	—	30 Sep 2022	13F
DEUTSCHE BANK AG\	13F	Company	0.3%	112,608	$1,001,000	—	30 Sep 2022	13F
Bank of New York Mellon Corp	13F	Company	0.29%	107,066	$952,000	—	30 Sep 2022	13F
Nuveen Asset Management, LLC	13F	Company	0.28%	103,865	$924,000	—	30 Sep 2022	13F
Defender Capital, LLC.	13F	Company	0.23%	86,450	$769,000	—	30 Sep 2022	13F
Albert D. Bolles	3/4/5	Chief Executive Officer	— class O/S missing	72,883	$759,441	—	23 May 2022	3/4/5
GOLDMAN SACHS GROUP INC	13F	Company	0.22%	81,917	$728,000	—	30 Sep 2022	13F
OPPENHEIMER ASSET MANAGEMENT INC.	13F	Company	0.22%	81,911	$728,000	—	30 Sep 2022	13F
GAMCO INVESTORS, INC. ET AL	13F	Company	0.21%	79,000	$702,000	—	30 Sep 2022	13F
ROYCE & ASSOCIATES LP	13F	Company	0.2%	75,610	$672,000	—	30 Sep 2022	13F
Ancora Advisors LLC	13F	Company	0.19%	70,549	$628,000	—	30 Sep 2022	13F
Tonia L. Pankopf	3/4/5	Director	— class O/S missing	59,599	$621,022	—	04 Jun 2022	3/4/5
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.18%	67,992	$605,000	—	30 Sep 2022	13F
Invesco Ltd.	13F	Company	0.17%	64,477	$574,000	—	30 Sep 2022	13F
Catherine A. Sohn	3/4/5	Director	— class O/S missing	54,069	$563,399	—	04 Jun 2022	3/4/5
BRIDGEWAY CAPITAL MANAGEMENT, LLC	13F	Company	0.15%	55,000	$489,000	—	30 Sep 2022	13F
LEWIS CAPITAL MANAGEMENT, LLC	13F	Company	0.13%	47,773	$425,000	—	30 Sep 2022	13F
D. E. Shaw & Co., Inc.	13F	Company	0.12%	46,403	$413,000	—	30 Sep 2022	13F
Deborah D. Carosella	3/4/5	Director	— class O/S missing	36,588	$381,247	—	04 Jun 2022	3/4/5
RHUMBLINE ADVISERS	13F	Company	0.11%	40,701	$362,000	—	30 Sep 2022	13F
Diversified Trust Co	13F	Company	0.1%	36,588	$325,000	—	30 Sep 2022	13F
Andrew Kenneth William Powell	3/4/5	Director	— class O/S missing	27,477	$286,310	—	04 Jun 2022	3/4/5
Tower Research Capital LLC (TRC)	13F	Company	0.08%	31,068	$277,000	—	30 Sep 2022	13F
Cutter & CO Brokerage, Inc.	13F	Company	0.08%	28,500	$253,000	—	30 Sep 2022	13F
Timothy P. Burgess	3/4/5	Senior VP of Supply Chain	— mixed-class rows	30,000 mixed-class rows	$239,704	—	27 Jul 2021	3/4/5
Keene & Associates, Inc.	13F	Company	0.07%	26,200	$233,000	—	30 Sep 2022	13F
MARTINGALE ASSET MANAGEMENT L P	13F	Company	0.07%	24,430	$218,000	—	30 Sep 2022	13F

Institutional Holders of LIFECORE BIOMEDICAL, INC. DE - Common Stock (LFCR) as of Q4 2022

As of 31 Dec 2022, LIFECORE BIOMEDICAL, INC. DE - Common Stock (LFCR) was held by 92 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 24,699,229 shares. The largest 10 holders included WYNNEFIELD CAPITAL INC, Legion Partners Asset Management, LLC, Cove Street Capital, LLC, BlackRock Inc., DIMENSIONAL FUND ADVISORS LP, 22NW, LP, VANGUARD GROUP INC, HEARTLAND ADVISORS INC, PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC., and MORGAN STANLEY. This page lists 93 institutional shareholders reporting positions in this security for the Q4 2022 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q4 2022 vs Q3 2022 Across Filers

Q3 2022 holders

Q4 2022 holders

Holder diff

Investor	Q3 2022 Shares	Q4 2022 Shares	Share Diff	Share Chg %	Q3 2022 Value $	Q4 2022 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.